<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-20-14</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-20-2-6</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Infectious Diseases</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Short-Term Antiepileptic Treatment of Solitary Cerebral Cysticercosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>02</month>
<year>2006</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>02</month>
<year>2016</year>
</pub-date>
<volume>20</volume>
<issue>2</issue>
<fpage>14</fpage>
<lpage>14</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2006 The Author(s)</copyright-statement>
<copyright-year>2006</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1111/j.1600-0404.2005.00538.x" vol="113" page="174">
<article-title>Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>A prospective randomized study of short-term vs long-term antiepileptic drug (AED) treatment of 206 subjects with new onset seizures and solitary cerebral cysticercus granuloma (SCCG) was conducted at the Department of Neurology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.</p>
</abstract>
<kwd-group>
<kwd>Antiepileptic Drug</kwd>
<kwd>Solitary Cerebral Cysticercus</kwd>
<kwd>Carbamazepine</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>A prospective randomized study of short-term vs long-term antiepileptic drug (AED) treatment of 206 subjects with new onset seizures and solitary cerebral cysticercus granuloma (SCCG) was conducted at the Department of Neurology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. Group A (98) patients were treated for 6 months and group B (108 patients) for 2 years. Patients were monitored during and 18 months or longer after tapering for 6 weeks and stopping treatment. Seizures were partial with or without secondary generalization in 80% of patients. Carbamazepine and phenytoin were used as first-line AEDs. Complete spontaneous resolution of the SCCG had occurred in 66.3% of group A patients and in 57.4% of group B, while the remaining patients showed punctated residual calcification on CT. Seizures recurred during the 18 month follow-up period in 3.1% and 4.8% of group A and B patients showing complete resolution of the granuloma (NS, P=0.61). In those with calcified residua, seizures recurred in 42.4% and 21.7% of groups A and B, respectively, and the difference was significant (P&#x003C;0.05). Seizures responded when therapy was resumed in all patients with recurrences. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENT. The study shows that solitary cerebral cysticercus granuloma with epilepsy is a self-limiting disease. In patients with complete resolution of the lesion on CT, early withdrawal of AED treatment after 6 months can be attempted without risk of seizure recurrence, whereas patients with persistent residual calcifications may require longer-term treatment.</p>
<p>Neurocysticercosis caused by infection of the CNS with <italic>Taenia solium</italic> is common in developing countries. It is rare in the USA but accounts for 25% of intracranial tumors in Mexico. A patient in India, a 16-year-old female, with a history of migraine, presented with headache that was prolonged, lasting longer than 72 hours (status migrainosus). Neurological examination was normal, with no papilledema. CT of the head showed hydrocephalus with disproportionate enlargement of the 4<sup>th</sup> ventricle. MRI revealed a solitary cystic lesion with scolex in the 4<sup>th</sup> ventricle that proved to be neurocysticercosis. Headache was partially relieved by IV mannitol and dexamethasone. Endoscopic removal of the cyst was unsuccessful because of adhesions. CT following 3rd ventriculostomy revealed reduction in size of 4<sup>th</sup> and lateral ventricles, and symptomatic relief. The patient was discharged on albendazole (400 mg BD orally for 14 days) and phenytoin 200 mg PM. At 6-month followup, she had suffered no headaches or seizures; CT showed a calcified dot in the 4<sup>th</sup> ventricle. [<xref ref-type="bibr" rid="CIT0002">2</xref>]</p>
<p>In a long-term study of 240 patients with seizures and neurocysticercosis in Mexico, outcome was better in patients who received albendazole [<xref ref-type="bibr" rid="CIT0003">3</xref>]. Seizures were fewer after medical treatment than after surgical excision of the cyst. (<bold>Ped Neur Briefs</bold> Oct 1992).</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verma</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Misra</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma</article-title>
<source>Acta Neurol Scand</source>
<month>Mar</month>
<year>2006</year>
<volume>113</volume>
<issue>3</issue>
<fpage>174</fpage>
<lpage>177</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-0404.2005.00538.x</pub-id>
<pub-id pub-id-type="pmid">16441247</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shukla</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Paliwal</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Jha</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Solitary fourth ventricular neurocysticercosis presenting as status migrainosus</article-title>
<source>Headache</source>
<month>Jan</month>
<year>2006</year>
<volume>46</volume>
<issue>1</issue>
<fpage>169</fpage>
<lpage>173</lpage>
<pub-id pub-id-type="doi">10.1111/j.1526-4610.2006.00316_3.x</pub-id>
<pub-id pub-id-type="pmid">16412167</pub-id>
</element-citation>
</ref>
<ref id="CIT0003">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasquez</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sotelo</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The course of seizures after treatment for cerebral cysticercosis</article-title>
<source>N Engl J Med</source>
<year>1992</year>
<month>Sep</month>
<day>3</day>
<volume>327</volume>
<issue>10</issue>
<fpage>696</fpage>
<lpage>701</lpage>
<pub-id pub-id-type="doi">10.1056/NEJM199209033271005</pub-id>
<pub-id pub-id-type="pmid">1495522</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>